In The Spotlight


biotechipo-may02.jpg IDEAYA Biosciences Inc. is an oncology-focused precision medicine company developing targeted therapeutics for patient populations selected using molecular diagnostics.

silkroad-may14.jpg Shares of Silk Road Medical Inc (SILK), which made their stock market debut in April, have since gained nearly 40%.

neogenomics-may06.jpg Shares of NeoGenomics Inc. (NEO), which have been hitting new highs, are up nearly 87% year-to-date.

biotechipo-may02.jpg In the healthcare sector, 2 companies made their debut on the NASDAQ in the first week of May - TransMedics Group (TMDX) at an offering price of $16 per share, and So-Young International (SY) at $13.80 per share.

marijuanaleaf-121511_30apr19.jpg Legal cannabis was one of the dominating headlines in 2018. Canada's legalization of marijuana for recreational use, legalization of recreational and medicinal marijuana in a number of U.S states, and FDA approval of the first cannabis-based medication, Epidiolex, to treat rare, severe forms of epilepsy have galvanized interests and investments in this sector.

biotechipo-march29.jpg Andover, Massachusetts-based TransMedics, Inc. is a commercial-stage medical device company whose proprietary system, Organ Care System, enables transplantation of beating hearts and other functioning organs.

inmunebio-041719.jpg Shares of INmune Bio Inc. (INMB) touched an all-time high of $11 on Tuesday (Apr.16), and that represents a gain of nearly 38% since their market debut in February.

biotechipo-march29.jpg Jerusalem, Israel-based Brainsway is a commercial stage medical device company marketing non-invasive neuromodulation products for the treatment of major depressive disorder and obsessive-compulsive disorder.

moderna-april08.jpg Shares of Moderna Therapeutics Inc. (MRNA), which had a splashy IPO last December, raising $604 million, considered the biggest-ever biotech IPO, touched a new high last week.

denalitherapeutics-april04.jpg Shares of Denali Therapeutics Inc. (DNLI) touched an all-time high of $26.93 on Wednesday, which represents a year-to-date gain of 32%.

biotechipo-march29.jpg In the healthcare sector, 1 company made its stock market debut in January, 12 in February, and 3 companies went to public in March.

biotechipo-feb04.jpg Loos, France-based Genfit S.A. is a late-stage clinical biopharmaceutical company developing innovative drug candidates and diagnostic solutions for metabolic and liver-related diseases.

ascendis-031219.jpg Shares of Ascendis Pharma A/S (ASND) closed yesterday's trading at an all-time high of $125.29, and that represents a gain of nearly 100% year-to-date.

lantheus-march05.jpg Shares of Lantheus Holdings Inc. (LNTH) are up an impressive 53% year-to-date, way ahead of the iShares Nasdaq Biotechnology ETF (IBB) index, which has gained only 20% during the same period.

biotechipo-feb04.jpg Santa Clara, California-based ShockWave Medical Inc. is a medical device company developing and marketing products based on intravascular lithotripsy (IVL) technology to treat calcified cardiovascular disease.

Follow RTT